why choose us

First received: October 30, 2023

Clinical Trial: Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Non Hodgkin Lymphoma

Study Type: OBSERVATIONAL


Official Title: A Prospective, Observational, Long-term Follow-up Study for Subjects Who Previously Received Zamtocabtagene Autoleucel in a United States Miltenyi Biomedicine-Sponsored Clinical Study

Brief Summary: This is an observational long-term follow-up (LTFU) study for subjects who previously received zamtocabtagene autoleucel, known as MB-CART2019.1.

Read more